Dolby Laboratories Sees Q4 EPS $0.61-$0.76 Vs $0.85 Est.; Revenue $300M-$320M Vs $326.6M Est.; FY24 EPS $3.60-$3.75 Vs $3.72 Est.; Revenue $1.27B-$1.29B Vs $1.29B Est.
Portfolio Pulse from Benzinga Newsdesk
Dolby Laboratories has provided its financial outlook for Q4 and FY24, with Q4 EPS estimated between $0.61-$0.76 vs. $0.85 expected, and revenue between $300M-$320M vs. $326.6M expected. FY24 EPS is estimated between $3.60-$3.75 vs. $3.72 expected, and revenue between $1.27B-$1.29B vs. $1.29B expected. The outlook is influenced by uncertainties such as supply chain constraints, geopolitical instability, and inflation.
August 07, 2024 | 8:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dolby Laboratories has provided a financial outlook for Q4 and FY24 that falls short of analyst expectations. Q4 EPS is estimated between $0.61-$0.76 vs. $0.85 expected, and revenue between $300M-$320M vs. $326.6M expected. FY24 EPS is estimated between $3.60-$3.75 vs. $3.72 expected, and revenue between $1.27B-$1.29B vs. $1.29B expected. The outlook is influenced by uncertainties such as supply chain constraints, geopolitical instability, and inflation.
Dolby's financial outlook for Q4 and FY24 falls short of analyst expectations, which is likely to negatively impact the stock price in the short term. The company cites uncertainties such as supply chain constraints, geopolitical instability, and inflation as factors affecting its outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100